Birchview Capital, LP’s Amicus Therapeutic Position
Does Birchview Capital, LP own Amicus Therapeutic (AM6)? Not currently — the last reported position was 253.0K shares worth $4M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q4 2025
Shares
253.0K
% of Portfolio
+2.11%
Quarters Held
29
position exited
Position History AM6
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 253.0K | $4M | +2.11% |
| Q3 2025 | 253.0K | $2M | +1.51% |
| Q2 2025 | 28.0K | $160,440 | +0.16% |
| Q1 2025 | 28.0K | $228,480 | +0.20% |
| Q4 2024 | 28.0K | $263,760 | +0.22% |
| Q3 2024 | 28.0K | $299,040 | +0.26% |
| Q2 2024 | 28.0K | $277,760 | +0.26% |
| Q1 2024 | 28.0K | $329,840 | +0.27% |
| Q4 2023 | 28.0K | $397,320 | +0.31% |
| Q3 2023 | 28.0K | $340,480 | +0.29% |
| Q2 2023 | 28.0K | $351,680 | +0.26% |
| Q1 2023 | 28.0K | $311 | +0.24% |
| Q4 2022 | 28.0K | $342 | +0.24% |
| Q3 2022 | 38.0K | $397,000 | +0.28% |
| Q2 2022 | 38.0K | $408,000 | +0.30% |
| Q1 2022 | 38.0K | $360,000 | +0.26% |
| Q4 2021 | 38.0K | $439,000 | +0.28% |
| Q3 2021 | 38.0K | $363,000 | +0.25% |
| Q2 2021 | 38.0K | $366,000 | +0.22% |
| Q1 2021 | 38.0K | $375,000 | +0.22% |
| Q4 2020 | 38.0K | $877,000 | +0.51% |
| Q3 2020 | 38.0K | $537,000 | +0.36% |
| Q2 2020 | 38.0K | $573,000 | +0.35% |
| Q1 2020 | 38.0K | $351,000 | +0.31% |
| Q4 2019 | 38.0K | $370,000 | +0.27% |
| Q3 2019 | 38.0K | $305,000 | +0.20% |
| Q2 2019 | 38.0K | $474,000 | +0.29% |
| Q1 2019 | 38.0K | $517,000 | +0.32% |
| Q4 2018 | 38.0K | $364,000 | +0.34% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of AM6.